AU709368B2 - Oral administration of pneumococcal antigens - Google Patents
Oral administration of pneumococcal antigens Download PDFInfo
- Publication number
- AU709368B2 AU709368B2 AU69985/96A AU6998596A AU709368B2 AU 709368 B2 AU709368 B2 AU 709368B2 AU 69985/96 A AU69985/96 A AU 69985/96A AU 6998596 A AU6998596 A AU 6998596A AU 709368 B2 AU709368 B2 AU 709368B2
- Authority
- AU
- Australia
- Prior art keywords
- pspa
- host
- antigen
- protection
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/458,399 US6231870B1 (en) | 1995-06-02 | 1995-06-02 | Oral administration of pneumoccal antigens |
US08/458399 | 1995-06-02 | ||
US08/482981 | 1995-06-07 | ||
US08/482,981 US6232116B1 (en) | 1991-02-15 | 1995-06-07 | Oral administration of pneumococcal antigens |
US08/657751 | 1996-05-30 | ||
US08/657,751 US6004802A (en) | 1995-06-02 | 1996-05-30 | Oral administration of pneumococcal antigens |
PCT/IB1996/001051 WO1996039113A2 (en) | 1995-06-02 | 1996-05-31 | Oral administration of pneumococcal antigens |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6998596A AU6998596A (en) | 1996-12-24 |
AU709368B2 true AU709368B2 (en) | 1999-08-26 |
Family
ID=27412732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69985/96A Ceased AU709368B2 (en) | 1995-06-02 | 1996-05-31 | Oral administration of pneumococcal antigens |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0871479A2 (fi) |
AU (1) | AU709368B2 (fi) |
CA (1) | CA2222965A1 (fi) |
FI (1) | FI974376A (fi) |
NO (1) | NO975522L (fi) |
WO (1) | WO1996039113A2 (fi) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19703437A1 (de) * | 1997-01-30 | 1998-08-06 | Luitpold Pharma Gmbh | Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen |
KR19980067137A (ko) * | 1997-01-31 | 1998-10-15 | 박원훈 | 알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신 |
DE19708537A1 (de) * | 1997-03-03 | 1998-09-10 | Biotechnolog Forschung Gmbh | Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc. |
WO2008109958A1 (en) * | 2007-03-15 | 2008-09-18 | Hunter Immunology Limited | Methods for evaluation of oral vaccines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992014488A1 (en) * | 1991-02-15 | 1992-09-03 | Uab Research Foundation | Structural gene of pneumococcal protein |
US5980909A (en) * | 1991-02-15 | 1999-11-09 | Uab Research Foundation | Epitopic regions of pneumococcal surface protein A |
US6027734A (en) * | 1991-02-15 | 2000-02-22 | Uab Research Foundation | Mucosal administration of pneumococcal antigens |
-
1996
- 1996-05-31 EP EP96931208A patent/EP0871479A2/en not_active Withdrawn
- 1996-05-31 WO PCT/IB1996/001051 patent/WO1996039113A2/en not_active Application Discontinuation
- 1996-05-31 CA CA002222965A patent/CA2222965A1/en not_active Abandoned
- 1996-05-31 AU AU69985/96A patent/AU709368B2/en not_active Ceased
-
1997
- 1997-12-01 NO NO975522A patent/NO975522L/no not_active Application Discontinuation
- 1997-12-01 FI FI974376A patent/FI974376A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
FI974376A0 (fi) | 1997-12-01 |
EP0871479A2 (en) | 1998-10-21 |
EP0871479A4 (fi) | 1998-11-11 |
WO1996039113A3 (en) | 1997-06-05 |
NO975522D0 (no) | 1997-12-01 |
NO975522L (no) | 1998-02-02 |
FI974376A (fi) | 1998-01-26 |
CA2222965A1 (en) | 1996-12-12 |
AU6998596A (en) | 1996-12-24 |
WO1996039113A2 (en) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Frasch | Vaccines for prevention of meningococcal disease | |
US6984385B2 (en) | Immunological combination compositions and methods | |
US20090098157A1 (en) | Helicobacter Pylori Vaccination | |
LEVINE et al. | Typhoid vaccines come of age | |
TWI570133B (zh) | 腦膜炎雙球菌[neisseria meningitidis]組合物及其方法 | |
AU2018201768A1 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
EP3056212A1 (en) | Non-lipidated variants of neisseria meningitidis orf2086 antigens | |
US20050260225A1 (en) | Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens | |
WO2017062558A1 (en) | Streptococcus suis polysaccharide-protein conjugate composition | |
AU698724B2 (en) | Mucosal administration of pneumococcal antigens | |
US6232116B1 (en) | Oral administration of pneumococcal antigens | |
US20120251577A1 (en) | Selectively disrupted whole-cell vaccine | |
US6004802A (en) | Oral administration of pneumococcal antigens | |
US6231870B1 (en) | Oral administration of pneumoccal antigens | |
US8518415B2 (en) | Engineered type IV pilin of Clostridium difficile | |
AU709368B2 (en) | Oral administration of pneumococcal antigens | |
Kaplonek et al. | A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae | |
WO2000076541A1 (en) | Pneumococcal surface protein combination vaccine | |
AU734488B2 (en) | Mucosal administration of pneumococcal antigens | |
Hara et al. | Outer membrane proteins as potential candidate vaccine targets |